PD‐L1/TIGIT bispecific antibody showed survival advantage in animal model

Bibliographic Details
Main Authors: Songlin Mu, Zhijuan Liang, Yongmei Wang, Wendi Chu, Yi‐Li Chen, Qi Wang, Guifeng Wang, Chunhe Wang
Format: Article
Language:English
Published: Wiley 2022-05-01
Series:Clinical and Translational Medicine
Online Access:https://doi.org/10.1002/ctm2.754
_version_ 1811241756154396672
author Songlin Mu
Zhijuan Liang
Yongmei Wang
Wendi Chu
Yi‐Li Chen
Qi Wang
Guifeng Wang
Chunhe Wang
author_facet Songlin Mu
Zhijuan Liang
Yongmei Wang
Wendi Chu
Yi‐Li Chen
Qi Wang
Guifeng Wang
Chunhe Wang
author_sort Songlin Mu
collection DOAJ
first_indexed 2024-04-12T13:40:55Z
format Article
id doaj.art-2c491c0ad96e42348e50acb6e5888efb
institution Directory Open Access Journal
issn 2001-1326
language English
last_indexed 2024-04-12T13:40:55Z
publishDate 2022-05-01
publisher Wiley
record_format Article
series Clinical and Translational Medicine
spelling doaj.art-2c491c0ad96e42348e50acb6e5888efb2022-12-22T03:30:50ZengWileyClinical and Translational Medicine2001-13262022-05-01125n/an/a10.1002/ctm2.754PD‐L1/TIGIT bispecific antibody showed survival advantage in animal modelSonglin Mu0Zhijuan Liang1Yongmei Wang2Wendi Chu3Yi‐Li Chen4Qi Wang5Guifeng Wang6Chunhe Wang7Biotherapeutics Discovery Research Center Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai ChinaBiotherapeutics Discovery Research Center Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai ChinaBiotherapeutics Discovery Research Center Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai ChinaBiotherapeutics Discovery Research Center Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai ChinaDartsbio Pharmaceuticals, Ltd. Zhongshan ChinaBiotherapeutics Discovery Research Center Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai ChinaBiotherapeutics Discovery Research Center Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai ChinaBiotherapeutics Discovery Research Center Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai Chinahttps://doi.org/10.1002/ctm2.754
spellingShingle Songlin Mu
Zhijuan Liang
Yongmei Wang
Wendi Chu
Yi‐Li Chen
Qi Wang
Guifeng Wang
Chunhe Wang
PD‐L1/TIGIT bispecific antibody showed survival advantage in animal model
Clinical and Translational Medicine
title PD‐L1/TIGIT bispecific antibody showed survival advantage in animal model
title_full PD‐L1/TIGIT bispecific antibody showed survival advantage in animal model
title_fullStr PD‐L1/TIGIT bispecific antibody showed survival advantage in animal model
title_full_unstemmed PD‐L1/TIGIT bispecific antibody showed survival advantage in animal model
title_short PD‐L1/TIGIT bispecific antibody showed survival advantage in animal model
title_sort pd l1 tigit bispecific antibody showed survival advantage in animal model
url https://doi.org/10.1002/ctm2.754
work_keys_str_mv AT songlinmu pdl1tigitbispecificantibodyshowedsurvivaladvantageinanimalmodel
AT zhijuanliang pdl1tigitbispecificantibodyshowedsurvivaladvantageinanimalmodel
AT yongmeiwang pdl1tigitbispecificantibodyshowedsurvivaladvantageinanimalmodel
AT wendichu pdl1tigitbispecificantibodyshowedsurvivaladvantageinanimalmodel
AT yilichen pdl1tigitbispecificantibodyshowedsurvivaladvantageinanimalmodel
AT qiwang pdl1tigitbispecificantibodyshowedsurvivaladvantageinanimalmodel
AT guifengwang pdl1tigitbispecificantibodyshowedsurvivaladvantageinanimalmodel
AT chunhewang pdl1tigitbispecificantibodyshowedsurvivaladvantageinanimalmodel